Imiquimod 3.75%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Imiquimod 3.75%, covering 2024-11-22 to 2024-11-22. Get the full timeline:
Most recent: Clinical Trial Update: Characterization of the Toll-like Receptor 7-agonist Imiquimod 3.75% As a New Surrogate Model of Itch [NA]